Extensive changes in the expression of the opioid genes between humans and chimpanzees

Brain, Behavior and Evolution

Volumn 76, Issue 2, 2010, Pages 154-162

  Cruz Gordillo, Peter ^a   Fedrigo, Olivier ^a   Wray, Gregory A ^a   Babbitt, Courtney C ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Gene expression; Nociception; Opioid peptides; Pain; Primate evolution

Indexed keywords

OPIATE PEPTIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN LEVEL; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; HUMAN; METHODOLOGY; MOLECULAR EVOLUTION; PAN TROGLODYTES; SPECIES DIFFERENCE;

ANIMALS; BRAIN CHEMISTRY; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OPIOID PEPTIDES; PAN TROGLODYTES; SPECIES SPECIFICITY;

PAN; PRIMATES;

EID: 78649232434     PISSN: 00068977     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320968     Document Type: Article

References (79)

1. Babbitt CC, Fedrigo O, et al (2010a): Both non-coding and protein-coding RNAs contribute to gene expression evolution in the primate brain. Genome Biol Evol 18: 67-79.
2. Babbitt CC, Silverman JS, et al (2010b): Multiple functional variants in cis modulate PDYN expression. Mol Biol Evol 27: 465-479.
3. Barr CS, Schwandt ML, et al (2008): Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proc Natl Acad Sci USA 105: 5277-5281.
4. Barrallo A, Gonzalez-Sarmiento R, et al (1998): Cloning, molecular characterization, and distribution of a gene homologous to delta opioid receptor f rom zebraf ish (Danio rerio). Biochem Biophys Res Commun 245: 544-548.
5. Benjamini Y, Hochberg Y (1995): Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-30 0.
6. Blanchette M, Batail le AR, et a l (2006): Genome-wide computational prediction of transcrip-tional regulatory modules reveals new insights into human gene expression. Genome Res 16: 656-668.
7. Bodnar RJ (2009): Endogenous opiates and behavior: 2008. Peptides 30: 2432-2479.
8. Bradford CS, Walthers EA, et al (2005): Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa. J Mol Endocrinol 34: 809-823. (Pubitemid 40903603)
9. Bradford CS, Walthers EA, et al (2006): Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization. Gen Comp Endocrinol 146: 275-290.
10. Chen JC, Smith ER, et al (1993a): The opioid receptor binding of dezocine, morphine, fen-tanyl, butorphanol and nalbuphine. Life Sci 52: 389-396. (Pubitemid 23020697)
11. Chen Y, Mestek A, et al (1993b): Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44: 8-12. (Pubitemid 23230453)
12. Chuang JH, Li H (2004): Functional bias and spatial organization of genes in mutational hot and cold regions in the human genome. PLoS Biol 2:E29. (Pubitemid 39234563)
13. Comb M, Seeburg PH, et al (1982): Primary structure of the human Met-and Leu-en-kephalin precursor and its mRNA. Nature 295: 663-666. (Pubitemid 12116136)
14. Cowley MA, Smart JL, et al (2001): Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
15. Crawford GE, Holt IE, et al (2006): Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 16: 123-131.
16. Dores RM, Lecaude S, et al (2002): Analyzing the evolution of the opioid/orphanin gene family. Mass Spectrom Rev 21: 220-243.
17. Drakenberg K, Nikoshkov A, et al (2006): Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci USA 103: 7883-7888.
18. Dreborg S, Sundstrom G, et al (2008): Evolution of vertebrate opioid receptors. Proc Natl Acad Sci USA 105: 15487-15492.
19. Edgar RC (2004): MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792-1797. (Pubitemid 38832724)
20. Fedrigo O, Warner LR, et al (2010): A pipeline to determine RT-QPCR control genes for evolutionary studies: application to primate gene expression across multiple tissues. PLoS One 5:e12545.
21. Gaffney DJ, Keightley PD (2005): The scale of mutational variation in the murid genome. Genome Res 15: 1086-1094.
22. Gong J, Strong JA, et al (1998): Endomorphins fully activate a cloned human mu opioid receptor. FEBS Lett 439: 152-156. (Pubitemid 28537883)
23. Harris JI (1959): Studies on pituitary polypeptide hormones. III. The structure of alpha-mela-nocyte-stimulating hormone from pig pituitary glands. Biochem J 71: 451-459.
24. Harris JI, Roos P (1959): Studies on pituitary polypeptide hormones. I. The structure of beta-melanocyte-stimulating hormone f rom pig pituitary glands. Biochem J 71: 434-445.
25. Haygood R, Fedrigo O, et al (2007): Promoter regions of many neural-and nutrition-related genes have experienced positive selection during human evolution. Nat Genet 39: 114 0-114 4. (Pubitemid 47340653)
26. Hellemans J, Mortier G, et al (2007): qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19. (Pubitemid 351851037)
27. Hellmann I, Zollner S, et al (2003): Selection on human genes as revealed by comparisons to chimpanzee cDNA. Genome Res 13: 831-837. (Pubitemid 36621743)
28. Huang CJ, Liu HF, et al (2008): Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia 63: 1288-1295.
29. Hurd YL (2002): Subjects with major depression or bipolar disorder show reduction of pro-dy norphin mR NA expression in discrete nuclei of the amygdaloid complex. Mol Psychiatry 7: 75-81.
30. Karolchik D, Baertsch R, et al (2003): The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-5 4. (Pubitemid 36150331)
31. Keightley PD, Lercher MJ, et al (2005): Evidence for widespread degradation of gene control regions in hominid genomes. PLoS Biol 3:e42.
32. Kennedy SE, Koeppe RA, et al (2006): Dysregu-lation of endogenous opioid emotion reg ula-tion circuitry in major depression in women. Arch Gen Psychiatry 63: 1199-1208.
33. Khaitovich P, Hellmann I, et al (2005): Parallel patterns of evolution in the genomes and transcriptomes of humans and chimpanzees. Science 309: 1850-1854. (Pubitemid 41325094)
34. Khaitovich P, Muetzel B, et al (2004): Regional patterns of gene expression in human and chimpanzee brains. Genome Res 14: 1462-1473. (Pubitemid 39198896)
35. K halap A, Bagrosk y B, et a l (20 05): Trends i n t he evolution of the proenkephalin and prodyn-orphin genes in gnathostomes. Ann NY Acad Sci 1040: 22-37. (Pubitemid 40979756)
36. Kondrashov FA, Rogozin IB, et al (2002): Selection in the evolution of gene duplications. Genome Biol 3:RESEARCH0008.
37. Kreek MJ (1996a): Opiates, opioids and addiction. Mol Psychiatry 1: 232-254.
38. Kreek MJ (1996b): Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 21: 14 69-14 88.
39. Kreek MJ, Bart G, et al (2005): Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57: 1-2 6. (Pubitemid 40283968)
40. Liu X, Kai M, et al (2009): Computational study of the heterodimerization between mu and delta receptors. J Comput Aided Mol Des 23: 321-332.
41. Meng F, Taylor LP, et al (1996): Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 271: 32016-32020. (Pubitemid 26422228)
42. Miller GM, Bendor J, et al (2004): A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Mol Psychiatry 9: 99-108. (Pubitemid 38175088)
43. Mollereau C, Parmentier M, et al (1994): ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341: 33-38. (Pubitemid 24089185)
44. Mollereau C, Simons MJ, et al (1996): Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 93: 8666-8670. (Pubitemid 26269617)
45. Ni koshkov A, Dra kenberg K, et al (2008): Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression. Proc Natl Acad Sci USA 105: 786-791. (Pubitemid 351171786)
46. Nikoshkov A, Hurd YL, et al (2005): Prodynor-phin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J 19: 1543-1545. (Pubitemid 41279025)
47. Noda M, Teranishi Y, et al (1982): Isolation and structural organization of the human pre-proenkephalin gene. Nature 297: 431-434. (Pubitemid 12025100)
48. Ogden CA, Rich ME, et al (2004): Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 9: 1007-1029.
49. Pan YX (2005): Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 24: 736-750.
50. Panopoulou G, Poustka AJ (2005): Timing and mechanism of ancient vertebrate genome duplications-the adventure of a hypothesis. Trends Genet 21: 559-567. (Pubitemid 41278461)
51. Pinal-Seoane N, Martin IR, et al (2006): Characterization of a new duplicate delta-opioid receptor from zebrafish. J Mol Endocrinol 37: 391-403. (Pubitemid 46085165)
52. Pond SL, Frost SD, et al (2005): HyPhy: hypothesis testing using phylogenies. Bioinformat-ics 21: 676-679.
53. R Development Core Team (2005): R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing (http://www.R-project.org).
54. Rockman MV, Hahn MW, et al (2005): Ancient and recent positive selection transformed opioid cis-regulation in humans. PLoS Biol 3: 2208-2219.
55. Rozas J, Sanchez-DelBarrio JC, et al (2003): DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformat-ics 19: 2496-2497. (Pubitemid 38016658)
56. Shabalina SA, Zaykin DV, et al (2009): Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18: 1037-1051.
57. Simonin F, Befort K, et al (1994): The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol 46: 1015-1021.
58. Simonin F, Gaveriaux-Ruff C, et al (1995): κ-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci USA 92: 7006-7010.
59. Snook LA, Milligan G, et al (2008): Co-expression of mu and delta opioid receptors as re-ceptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms. J Neurochem 105: 865-873. (Pubitemid 351562745)
60. Sonetti D, Peruzzi E, et al (2005): Endogenous morphine and ACTH association in neural tissues. Med Sci Monit 11:MS22-MS30. (Pubitemid 40790946)
61. Sorek R, Ast G (2003): Intronic sequences flanking alternatively spliced exons are conserved between human and mouse. Genome Res 13: 1631-1637. (Pubitemid 36874480)
62. Stein C, Zollner C (2009): Opioids and sensory nerves. Handb Exp Pharmacol 194: 495-518.
63. Stevens CW (2009): The evolution of vertebrate opioid receptors. Front Biosci 14: 1247-1269.
64. Stevens CW, Brasel CM, et al (2007): Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. Neurosci Lett 419: 189-194.
65. Sundstrom G, Dreborg S, et al (2010): Concomitant duplications of opioid peptide and receptor genes before the origin of jawed vertebrates. PLoS One 5:e10512.
66. Telkov M, Geijer T, et al (1998): Human prodyn-orphin gene generates several tissue-specific transcripts. Brain Res 804: 284-295. (Pubitemid 28496632)
67. Uddin M, Wildman DE, et al (2004): Sister grouping of chimpanzees and humans as revealed by genome-wide phylogenetic analysis of brain gene expression profiles. Proc Nat l Acad Sci USA 101: 2957-2962. (Pubitemid 38327718)
68. Vallender EJ, Priddy CM, et al (2008): Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque. Behav Genet 38: 390-395.
69. Vandesompele J, De Preter K, et al (2002): Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
70. Walthers EA, Bradford CS, et al (2005): Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Tarich a g ranulosa. J Mol Endocr i nol 3 4: 247-256.
71. Wong WSW, Nielsen R (2004): Detecting selection in noncoding regions of nucleotide sequences. Genetics 167: 949-958. (Pubitemid 38931879)
72. Wray GA, Hahn MW, et al (2003): The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol 20: 1377-1419.
73. Xuei X, Dick D, et al (2006): Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11: 1016-1024. (Pubitemid 44631644)
74. Xuei X, Flury-Wetherill L, et al (2007): The opi-oid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet 144: 877-884. (Pubitemid 47547987)
75. Yuferov V, Ji F, et al (2009): A functional haplo-type implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34: 1185-1197.
76. Zaveri N, Polgar WE, et al (2001): Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors. Eur J Pharmacol 428: 29-36. (Pubitemid 32971754)
77. Zhang JZ, Nielsen R, et al (2005a): Evaluation of an improved branch-site likelihood method for detecting positive selection at the molec-u lar level. Mol Biol Evol 22: 2472-2479. (Pubitemid 41661383)
78. Zhang Y, Wang D, et al (2005b): Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280: 32618-32624. (Pubitemid 41368304)
79. Zi mprich A, Kraus J, et a l (20 00): An a l lelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. J Neurochem 74: 472-477. (Pubitemid 30053718)